NIH diabetes research
This article was originally published in The Tan Sheet
Executive Summary
Several NIH institutes and offices are providing roughly $4 mil. in FY 2004 to fund 12-15 collaborative research projects, according to June 26 1request for applications. Office of Dietary Supplements, National Institute of Diabetes & Digestive & Kidney Diseases, National Institute of Allergy & Infectious Diseases are among the sponsors. RFA is designed to "attract new research talent to type 1 diabetes research...and facilitate the formation of interdisciplinary research partnerships." Applicants for collaborative R01 grants may seek project period of up to two years and combined budget "within a collaborative group may not exceed $300,000 in direct costs per year." Applications are due Nov. 13...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.